Angiogenic growth factor axis in autophagy regulation

Marissa J. Stanton, Samikshan Dutta, Navatha Shree Polavaram, Sohini Roy, Michael H. Muders, Kaustubh Datta

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Understanding the molecular mechanisms promoting therapy resistance is important. Previously, we reported that VEGFC can promote cancer cell survival during stress via interaction with its receptor NRP2. While examining the molecular mechanisms involved in this survival, we performed a microarray study in which we identified two genes, WDFY1 and LAMP2, which have been suggested to function in autophagy. Our subsequent studies further confirmed the regulation of autophagy by the VEGFCNRP2 axis in cancer during starvationand chemotherapy-induced stress. We are currently in the process of determining the mechanism(s) through which WDFY1 and LAMP2 control autophagy; however, we did observe an increase in MTOR complex 1 (MTORC1) activity after the depletion of the VEGFC-NRP2 axis. It would therefore be interesting to study whether WDFY1 and LAMP2 can influence MTORC1 activity and regulate autophagy. Taken together, our data suggest that targeting the VEGFCNRP2 axis in combination with chemotherapy could be an effective treatment for advanced cancers.

Original languageEnglish (US)
Pages (from-to)789-790
Number of pages2
JournalAutophagy
Volume9
Issue number5
DOIs
StatePublished - May 2013

Fingerprint

Angiogenesis Inducing Agents
Autophagy
Intercellular Signaling Peptides and Proteins
Neoplasms
Combination Drug Therapy
Cell Survival
Drug Therapy
Therapeutics
Genes

Keywords

  • Autophagy
  • Chemotherapy
  • LAMP-2
  • NRP-2
  • VEGF-C
  • WDFY1

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Stanton, M. J., Dutta, S., Polavaram, N. S., Roy, S., Muders, M. H., & Datta, K. (2013). Angiogenic growth factor axis in autophagy regulation. Autophagy, 9(5), 789-790. https://doi.org/10.4161/auto.23783

Angiogenic growth factor axis in autophagy regulation. / Stanton, Marissa J.; Dutta, Samikshan; Polavaram, Navatha Shree; Roy, Sohini; Muders, Michael H.; Datta, Kaustubh.

In: Autophagy, Vol. 9, No. 5, 05.2013, p. 789-790.

Research output: Contribution to journalArticle

Stanton, MJ, Dutta, S, Polavaram, NS, Roy, S, Muders, MH & Datta, K 2013, 'Angiogenic growth factor axis in autophagy regulation', Autophagy, vol. 9, no. 5, pp. 789-790. https://doi.org/10.4161/auto.23783
Stanton MJ, Dutta S, Polavaram NS, Roy S, Muders MH, Datta K. Angiogenic growth factor axis in autophagy regulation. Autophagy. 2013 May;9(5):789-790. https://doi.org/10.4161/auto.23783
Stanton, Marissa J. ; Dutta, Samikshan ; Polavaram, Navatha Shree ; Roy, Sohini ; Muders, Michael H. ; Datta, Kaustubh. / Angiogenic growth factor axis in autophagy regulation. In: Autophagy. 2013 ; Vol. 9, No. 5. pp. 789-790.
@article{63571d7e0a0941d6bed4e372bf69725b,
title = "Angiogenic growth factor axis in autophagy regulation",
abstract = "Understanding the molecular mechanisms promoting therapy resistance is important. Previously, we reported that VEGFC can promote cancer cell survival during stress via interaction with its receptor NRP2. While examining the molecular mechanisms involved in this survival, we performed a microarray study in which we identified two genes, WDFY1 and LAMP2, which have been suggested to function in autophagy. Our subsequent studies further confirmed the regulation of autophagy by the VEGFCNRP2 axis in cancer during starvationand chemotherapy-induced stress. We are currently in the process of determining the mechanism(s) through which WDFY1 and LAMP2 control autophagy; however, we did observe an increase in MTOR complex 1 (MTORC1) activity after the depletion of the VEGFC-NRP2 axis. It would therefore be interesting to study whether WDFY1 and LAMP2 can influence MTORC1 activity and regulate autophagy. Taken together, our data suggest that targeting the VEGFCNRP2 axis in combination with chemotherapy could be an effective treatment for advanced cancers.",
keywords = "Autophagy, Chemotherapy, LAMP-2, NRP-2, VEGF-C, WDFY1",
author = "Stanton, {Marissa J.} and Samikshan Dutta and Polavaram, {Navatha Shree} and Sohini Roy and Muders, {Michael H.} and Kaustubh Datta",
year = "2013",
month = "5",
doi = "10.4161/auto.23783",
language = "English (US)",
volume = "9",
pages = "789--790",
journal = "Autophagy",
issn = "1554-8627",
publisher = "Landes Bioscience",
number = "5",

}

TY - JOUR

T1 - Angiogenic growth factor axis in autophagy regulation

AU - Stanton, Marissa J.

AU - Dutta, Samikshan

AU - Polavaram, Navatha Shree

AU - Roy, Sohini

AU - Muders, Michael H.

AU - Datta, Kaustubh

PY - 2013/5

Y1 - 2013/5

N2 - Understanding the molecular mechanisms promoting therapy resistance is important. Previously, we reported that VEGFC can promote cancer cell survival during stress via interaction with its receptor NRP2. While examining the molecular mechanisms involved in this survival, we performed a microarray study in which we identified two genes, WDFY1 and LAMP2, which have been suggested to function in autophagy. Our subsequent studies further confirmed the regulation of autophagy by the VEGFCNRP2 axis in cancer during starvationand chemotherapy-induced stress. We are currently in the process of determining the mechanism(s) through which WDFY1 and LAMP2 control autophagy; however, we did observe an increase in MTOR complex 1 (MTORC1) activity after the depletion of the VEGFC-NRP2 axis. It would therefore be interesting to study whether WDFY1 and LAMP2 can influence MTORC1 activity and regulate autophagy. Taken together, our data suggest that targeting the VEGFCNRP2 axis in combination with chemotherapy could be an effective treatment for advanced cancers.

AB - Understanding the molecular mechanisms promoting therapy resistance is important. Previously, we reported that VEGFC can promote cancer cell survival during stress via interaction with its receptor NRP2. While examining the molecular mechanisms involved in this survival, we performed a microarray study in which we identified two genes, WDFY1 and LAMP2, which have been suggested to function in autophagy. Our subsequent studies further confirmed the regulation of autophagy by the VEGFCNRP2 axis in cancer during starvationand chemotherapy-induced stress. We are currently in the process of determining the mechanism(s) through which WDFY1 and LAMP2 control autophagy; however, we did observe an increase in MTOR complex 1 (MTORC1) activity after the depletion of the VEGFC-NRP2 axis. It would therefore be interesting to study whether WDFY1 and LAMP2 can influence MTORC1 activity and regulate autophagy. Taken together, our data suggest that targeting the VEGFCNRP2 axis in combination with chemotherapy could be an effective treatment for advanced cancers.

KW - Autophagy

KW - Chemotherapy

KW - LAMP-2

KW - NRP-2

KW - VEGF-C

KW - WDFY1

UR - http://www.scopus.com/inward/record.url?scp=84877329400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877329400&partnerID=8YFLogxK

U2 - 10.4161/auto.23783

DO - 10.4161/auto.23783

M3 - Article

C2 - 23388383

AN - SCOPUS:84877329400

VL - 9

SP - 789

EP - 790

JO - Autophagy

JF - Autophagy

SN - 1554-8627

IS - 5

ER -